Rubicon Research has convened its 27th Annual General Meeting (AGM) for Wednesday, August 26, 2026, at 1:00 P.M. (IST) via video conferencing, seeking shareholder approval for a final dividend of ₹1.50 per equity share and the strategic merger of its wholly owned subsidiary, KIA Health Tech Private Limited. The meeting represents a critical governance milestone for the pharmaceutical company, which listed on Indian exchanges in October 2025, as it seeks to streamline operations through internal consolidation while rewarding investors with a payout that reflects its strong FY26 financial performance.

The Board of Directors recommended the dividend based on consolidated profit after tax of ₹2,467 million for the financial year ended March 31, 2026. The record date for determining dividend entitlement is fixed for Friday, August 7, 2026. Payment will be made electronically within 30 days of the AGM, subject to applicable tax deduction at source. The total dividend payout is estimated at approximately ₹25 crore, representing a payout ratio of 13.29% of standalone profits after tax.

Key Agenda Items

Beyond the dividend declaration, the AGM notice outlines several special business resolutions aimed at enhancing corporate efficiency and employee retention. The most significant operational change is the proposed Scheme of Merger under Section 233 of the Companies Act, 2013, which will amalgamate KIA Health Tech Private Limited into the parent company. The merger is designed to eliminate duplicate compliance costs, optimize resource utilization, and simplify the corporate structure without issuing new shares or altering the existing shareholding pattern.

The company is also seeking approval for the Rubicon Research Limited Stock Options Plan 2026 (ESOP 2026). This plan creates a pool of 24,84,415 employee stock options, including unutilized options from the previous scheme, to attract and retain talent. Additionally, shareholders will approve revised remuneration for non-executive independent directors, increasing annual fees to ₹3.50 million for the Audit Committee Chairperson and ₹3.00 million for other independent directors, effective October 1, 2026.

Voting and Participation

Remote e-voting will commence on Saturday, August 22, 2026, at 9:00 A.M. (IST) and conclude on Tuesday, August 25, 2026, at 5:00 P.M. (IST). Members holding shares as of the cut-off date, Wednesday, August 19, 2026, are eligible to vote. The facility for appointing proxies is not available for this virtual meeting. M/s. SGGS & Associates has been appointed as the scrutinizer to oversee the e-voting process, ensuring transparency and compliance with SEBI Listing Regulations and the Companies Act, 2013.

Rubicon Research Limited has scheduled an earnings conference call for Friday, August 14, 2026, at 6:00 PM IST, to discuss the company's financial performance for the quarter ended June 30, 2026. The announcement was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Company Secretary Deepashree Tanksale on August 7, 2026.

Senior Management Representation

The Q1FY27 earnings concall will be represented by the following senior management members:

• Mr. Parag Sancheti – Chief Executive Officer
• Mr. Nitin Jajodia – Chief Financial Officer
• Mr. Sagar Oak – Senior Vice President, Corporate Development & Strategy

The call will be moderated by Tushar Manudhane, Executive Director – Healthcare at Motilal Oswal Financial Services, serving as the Call Leader.

Conference Call Schedule

The earnings call is scheduled across multiple time zones to facilitate participation from investors and stakeholders globally. The following table outlines the call timings by region:

Dial-In Details

Participants can join the conference call using the following dial-in numbers:

An Express Login option via Diamond Pass is also available for participants seeking direct access to the call. The conference call will cover the company's financial performance for the quarter ended June 30, 2026, along with a discussion on the way forward as presented by senior management.